retatrutide triple agonist weight loss trial ๐จ Today, retatrutide, the GIP/GLP-1/glucagon agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and type 2 diabetes. ๐ Mean body change at 80 weeks: โฌ๏ธ Lilly orforglipron oral GLP-1 phase
Pay in 4 interest-free payments of $7.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 14 - Aug 19




:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)












:max_bytes(150000):strip_icc():focal(749x0:751x2)/oatzempic-040124-5-c01290c2c2d8468c9fcfa1195527e52a.jpg)










